Coronary Artery Bypass Graft Market - Top Companies and Manufacturers

Companies Dominating the Coronary Artery Bypass Graft Market

Key players in the coronary artery bypass graft market are contributing through innovations in surgical techniques, technology, and healthcare solutions. Investments and partnerships among government and private sectors are improving the quality and accessibility of CABG procedures and are also contributing to the overall growth of the market by making the surgeries more efficient across diverse regions.

Here are some key players in the coronary artery bypass graft market:

Medtronic, plc

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

Guidant Group
Xeltis BV
MAQUET Holding B.V. & Co.KG
Novadaq Technologies Inc.
KARL STORZ GmbH & Co. KG
Edwards Lifesciences Corporation
Genesee Biomedical Inc.
Sorin Group
Kimal PLC

Browse Key Market Insights with Data Illustration:

Coronary Artery Bypass Graft Market Size & Share, Forecast Report 2037

In the News

In February 2023, Xeltis, a medical technology firm situated in Eindhoven, the Netherlands, raised USD 33.65 million in a Series D2 equity funding round. The company is pioneering a restorative approach to heart valve replacement and vascular therapy, based in part on research conducted at Eindhoven University of Technology.
In February 2023, Kimal PLC announced a new strategic partnership with Marizyme, Inc. for DuraGraft, the company's flagship product. This collaboration will combine Marizyme's expertise in creating novel medical device technology with Kimal's broad distribution network and specialized market understanding. Together, the companies will bring DuraGraft to market more efficiently and effectively, resulting in a larger network of healthcare practitioners and patients who can benefit from DuraGraft during CABG surgeries.

Frequently Asked Questions (FAQ)

The global coronary artery bypass graft market registered a valuation of USD 14.09 billion in 2024 and is poised to expand at a CAGR of 9.2% during the forecast period, i.e., 2025-2037.

The global coronary artery bypass graft sector registered a profitable valuation of USD 14.09 billion in 2024 and is poised to register USD 44.25 billion in 2037 expanding at a CAGR of 9.2% during the forecast period, i.e., 2025-2037.

The major players in the market are Guidant Group, MAQUET Holding B.V. & Co.KG, Novadaq Technologies Inc., KARL STORZ GmbH & Co. KG, Edwards Lifesciences Corporation, Genesee Biomedical Inc., and others.

By method, the off-pump segment is poised to register the largest revenue share of 56.2% by 2037. The market growth can be attributed to off-pump CABG’s reduced complications, faster recovery, and advancements in surgical technology.

North America is poised to register the largest revenue share of 49.8% by the end of 2037. The market growth is attributed to the rising prevalence of cardiovascular diseases, particularly CAD.

Coronary Artery Bypass Graft Market - Top Companies and Manufacturers

Companies Dominating the Coronary Artery Bypass Graft Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the coronary artery bypass graft market?

What is the outlook for the coronary artery bypass graft market?

Who are the major players dominating the coronary artery bypass graft market?

Which method segment will capture the significant market share for the coronary artery bypass graft sector by 2037?

Which region will provide more business opportunities for the growth of the coronary artery bypass graft market in the future?